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Abstract
Objectives: Scrophularia striata Boiss (Scrophular-
iaceae) is a plant that grows in northeastern Iran; it
has been used traditionally to treat various inflam-
matory disorders. This study was designed to
investigate cytotoxic effects of S. striata extract, on
the Jurkat human leukaemia cell line (T-cell leu-
kaemia).
Materials and methods: Phytochemical assay by
thin layer chromatography and 2, 2 diphenyl-1-pic-
ryl-hydrazyl were used to evaluate main com-
pounds and antioxidant capacity of the plant
extract, respectively. Its inhibitory effect on Jurkat
cells was evaluated by MTT assay. In addition, cell
cycle distribution and apoptotic cell death were
evaluated by propidium iodide and annexin V-
FITC/ propidium iodide staining.
Results: These showed that the main components
present in S. striata extract included flavonoids, phe-
nolic compounds and phenyl propanoids. Treatment
with extract was significantly cytotoxic to the tumour
cell line. In addition, flow cytometry analysis indi-
cated that S. striata extract induced cell cycle arrest
in G2/M phase and apoptosis of tumour cells.
Conclusions: Results of the study indicated that
S. striata extract could inhibit leukaemia cell prolifer-
ation by inducing G2/M phase arrest and apoptosis.
Introduction
Malignancy is one of the leading causes of death in the
world. Although traditional cancer therapies, including sur-
gery, chemotherapy and radiotherapy, are the standard
methods of patient treatment, they are not fully effective.
Using natural agents such as medicinal plants, in tumour
therapy arouses extensive interest, aspiring to minimal side
effects, better safety and efficiency. Many of the most useful
anti-cancer drugs (including vinblastin, vincristine, etopo-
side and taxol) that have been approved for use in anti-can-
cer therapy, are plant-derived compounds (1–5); in addition,
during our course of study on different medicinal plants, we
have found inhibitory effects of several plants on tumour
cell proliferation (6,7). Scrophularia striata Boiss (Scrophu-
lariaceae) is a plant that grows in northeastern Iran that has
been used as a traditional herb for various purposes. Several
species of Scrophularia have been used in folk medicine
since ancient times, as a sedative and for treatment of ill-
nesses such as scrophula, scabies, eczema, psoriasis and
tumours. Our previous in vitro studies have demonstrated
inhibitory effects of S. striata extract on nitric oxide pro-
duction and on pro-inflammatory cytokine (including TNF-
a, IL-1b and PGE2) production by macrophages (8,9). In
addition, anti-tumour, anti-inflammatory and immunomodu-
latory activities of some species of Scrophularia have been
shown by other investigators (10–13). Moreover, several
compounds from various Scrophularia species with anti-
inflammatory and neuroprotective properties (including irid-
oids and phenyl propanoids) have been isolated. Further,
flavonoids, phenolic compounds, quercetin and isorhamne-
tin 3-O-rutinoside, with antioxidant activity, have also been
identified from S. striata (14). In the present study, we
investigated cytotoxic effects and induction of apoptosis of
S. striata in the Jurkat human leukaemia cell line.
Materials and methods
Plant material and extract preparation
Aerial parts of S. striata were collected from the Ruin
region of northeastern Iran, in May 2010, and air dried
at room temperature. A sample was authenticated by Dr
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Faride Attar, from Tehran University, Faculty of Sci-
ences and a voucher specimen (Herbarium No: 36501)
was preserved in the herbarium of the Tehran University
Faculty of Sciences, Tehran, Iran. Aerial components of
the plant were dried, powdered (20 g) and macerated in
80% ethanol solution for 3 days with three changes of
solution. Resulting extract was filtered and evaporated
under vacuum into the final dried powder of S. striata.
Extract including phenyl propanoids, phenolic com-
pounds and flavonoids dissolved in dimethylsulphoxide
(% 0.1 v/v); this process was performed here.
Phytochemical assay
To be able to identify chemical components of the
extract, thin-layer chromatography was performed. A
variety of indicators including vanillin sulphuric acid,
ferric chloride and natural product polyethylene glycol
were used. Indictors were sprayed on prepared thin lay-
ers of extract and were observed at 260 and 280 nm
wavelengths under UV light.
DPPH assay
DPPH testing was used to evaluate antioxidant capacity
of the plant extract. Briefly, one thousand microlitres of
selected concentrations (250, 125, 62.5, 31.25, 15.62 and
7.81 lg/ml) of S. striata extract in ethanol was added to
4 ml of 0.004% methanolic solution of DPPH. After
60 min incubation at room temperature, absorbance was
read against a blank at 517 nm. Inhibition of free radical
by DPPH percent (I%) was calculated as follows:
I% ¼ ðAblank  AsampleÞ
Ablank
 
100
Ablank is the Absorbance of control reaction (containing
all reagents except the test compound).
Asample is the Absorbance of test compound. Extract
concentration providing 50% inhibition (IC50%) was cal-
culated from the graph inhibition percentage against
extract concentration. IC50% values were compared to
IC50% value of a ‘standard’ antioxidant, in this case
ascorbic acid (AA), obtained by the same procedure.
Measurement of total phenolic compounds
Total phenolic content of the dry herb was determined
by using Folin-Ciocalteau assay.
One aliquot (1 ml) of extract or standard solution of
gallic acid (20, 40, 60, 80 and 100 mg/l) was added to
25 ml in a volumetric flask, containing 9 ml of distilled
deionized water (dd H2O) and a reagent blank using dd
H2O was prepared. One millilitre Folin-Ciocalteu’s phe-
nol reagent was added to the mixture and shaken. After
5 min, 10 ml 7% Na2CO3 solution was added to the
mixture, the solution was diluted to 25 ml with dd H2O
and mixed. After incubation for 90 min at room temper-
ature, absorbance against the prepared reagent blank was
determined at 750 nm. Data of total phenolic contents
are expressed as milligrams gallic acid equivalents
(GAE) per gram dry weight (mgGAE/gDW). All samples
were analysed in duplicate.
Cell culture
Jurkat tumour cell line (T cell leukaemia) prepared from
the National Cell Bank of Iran and maintained by cultur-
ing in RPMI 1640 medium (Sigma, St Louis, MO,
USA), was supplemented with 10% heat-inactivated
foetal calf serum (Gibco-BRL Grand Island, NY,
USA), 2 mM L-glutamine, 100 lg/ml streptomycin and
100 U/ml penicillin. Cell viability was determined using
the trypan blue dye exclusion test.
Cell viability assay
Effects of S. striata extract on the Jurkat human tumour
cell line were determined using MTT (3-(4, 5-dim-
ethylthiazoyl)-2, 5- diphenyltetrazolium bromide) assay.
Briefly, cells were added to flat-bottomed micro-culture
plates in the presence or absence of selected concentra-
tions (50, 100, 200 and 400 lg/ml) of the extracts (in
triplicate) and incubated at 37 °C, in 5% humidified
CO2 for 48 h. Then, 10 ll of MTT (5 mg/ml, Sigma)
was added to each well and incubation continued for
further 4 h at 37 °C. In each well, 100 ll/well solubili-
zation solution, containing isopropanol and 10% SDS in
0.01 M HCl, was added. After complete solubilization of
formazan crystals, plates were read at 570 nm on an
ELISA reader; reference wavelength was 690 nm. Mean
optical density (OD)  SD for each group of replicates
was calculated. Percent inhibition of cells exposed to
various treatments was obtained as follows:
%Cell viability ¼ 100 Test OD
Non-treated OD
 
100
 
:
Annexin V-FITC/PI apoptosis assay
To determine apoptosis, an Annexin V–FITC apoptosis
Detection Kit (Invitrogen, Carlsbad, CA, USA) was
used, according to the manufacturer’s protocol. Briefly,
1 9 105 cells/ml were treated with the selected concen-
trations (50, 100, 200 and 400 lg/ml) of S. striata
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extract, for 24 h at 37 °C. Cells were then harvested and
re-suspended in binding buffer. They were then stained
with 10 ll AnnexinV–FITC and 5 ll propidium iodide
(PI) for 15 min at room temperature in the dark. Apopto-
tic index was immediately determined by flow cytometry.
Cell cycle analysis
Cells (1 9 105 cells/ml) were treated with the selected
concentrations (50, 100, 200 and 400 lg/ml) of the
extract for 24 h; they were then centrifuged and fixed in
70% ethanol. After washing, cells were resuspended in
1 ml PBS containing 10 mg/ml RNase and 1 mg/ml PI
(Sigma); they were then incubated for 1 h at 37 °C in the
dark. Thereafter, cells were analysed on a FACScalibur
flow cytometer (Becton-Dickinson, San Jose, CA, USA).
Taxol treatment (1.75 lg/ml) was used as positive control.
DNA fragmentation analysis
In this study, isolation of fragmented DNA from Jurkat
cells cultured in 24-well plates was carried out according
to the procedure of Amirghofran et al., with modifica-
tions (7). Briefly, 2 9 106 cells/ml were treated with
plants extract then collected by centrifugation (2000 g,
10 min). Pellets were resuspended in 0.5 ml DNA lysis
buffer (2% SDS, 10 mM EDTA, 10 mM Tris-Hcl, pH 8.5)
and lysate was immediately incubated with 0.1 mg/ml
proteinase k (Sigma) before being incubated for 3 h at
37 °C. After addition of isopropanol, DNA was precipi-
tated with 70% ethanol. The suspension was then centri-
fuged, and DNA treated with 100 ll 10 mM Tris-HCl (pH
7.5) and 0.5 mg/ml RNase A (Boehringer Mannheim,
Mannheim, Germany), at 37 °C for 24 h. Samples were
then loaded into 2% agarose gels containing ethidium bro-
mide, and were electrophoresed. DNA bands was visual-
ized under ultraviolet illumination and photographed.
Statistical analysis
Data are presented as mean  SD. Statistical analyses
were performed by one-way analysis of variance (ANO-
VA) and a post–hoc Bonferroni test to express the dif-
ference among the groups. All analyses were performed
using SPSS 16. Data were considered statistically signif-
icant at P < 0.05.
Results
Chemical components of the extract
Phytochemical assay by thin layer chromatography
revealed S. striata extract’s main components including
phenyl propanoids, phenolic compounds and flavonoids
(Table 1).
Measurement of total phenolic compounds and
antioxidant activity
Phenolic compounds are well recognized as antioxidants
which can act as free radical terminators (15) and have
been known to show medicinal activity as well as to
exhibit physiological functions (16). In this study, we
used Folin-Ciocalteau assay for standardizing aerial parts
of S. striata and quantity of total phenolic compounds;
flavonoids and phenolic compounds of dry herb were
measured respectively, as shown in Table 2, with gallic
acid as standard. In addition, free radical scavenging
capacities of the extract were measured by DPPH assay
and results are also provided in Table 2, with ratios
(IC50%) AA/(IC50%) extract shown. These represent AA
equivalent of the extract antioxidant capacity, that is,
amount of AA in milligram equivalent to one gram of
extract.
Effect of S. striata extract on tumour cell viability
In this study, normal human peripheral blood mononu-
clear cells (PBMCs) were used as normal cells com-
pared to the test Jurkat human leukaemia cells. In a
preliminary experiment on PBMCs, results indicated that
extract up to 400 lg/ml had no significant toxicity over
48 h. Thus, the Jurkat cells were incubated with selected
concentrations (0–400 lg/ml) of extract for 48 h. As
shown Fig. 1, extract significantly (P < 0.05) inhibited
Jurkat cell proliferation in a dose- and time-dependent
Table 1. Phytochemical results of Scrophularia striata extract
Compounds Reagents Standards Results
Phenylpropanoids
and terpenoids
Vanillin sulphuric acid Cinamic acid +
Phenolic compounds Ferric chloride Nepitrin +
Flavonoids Natural product
reagent
Quercetin +
Table 2. Measurement of phenolic compounds and antioxidant capac-
ity of Scrophularia striata extract
Total phenolic
compounds
in dry herb
(mgGAE/gdw)
DPPH radical
scavenging
activity, IC50%
(mg/l)
Ascorbic acid
equivalent of the
extract antioxidant
capacity (mg/g)
10.96 316.69 29.8
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manner. For example, treatment with 400 lg/ml of
extract for 48 h resulted in 58% Jurkat cells proliferation
inhibition. Results indicate that this extract can induce a
cytotoxic effect on Jurkat human leukaemia cells.
Effect of S. striata extract on apoptosis of Jurkat cells
To determine whether the cytotoxic effect of S. striata
extract on Jurkat cells was related to apoptotic cell
death, we evaluated phosphatidylserine exposure as an
early marker of apoptosis, using annexin V-FITC/PI
double staining. In control (untreated) groups, 92.2%
cells were viable, 7.5% cells were in the early and late
stages of apoptosis (lower right + upper right). While,
after 24-h treatment with S. striata extract, the apoptotic
cell population increased from 19.2 to 53.3% when
extract concentration increased from 50 to 400 lg/ml.
As shown in Fig. 2, percentages of Annexin V-positive
cells increased gradually in a dose-dependent manner
after S. striata extract treatment, suggesting that the
extract induced the apoptotic response.
Effect of S. striata extract on Jurkat cell cycle
distribution
To determine whether anti-tumour and proliferation-
inhibitory effects of S. striata extract on Jurkat cells was
related to induction of cell cycle arrest, distribution of
cells in different phases of the cell cycle was evaluated
by measuring DNA content. As shown in Fig. 3, after
treatment with different doses of S. striata extract for
24 h, proportions of cells in G2/M increased from 4.3 to
28.2% compared to control groups. In addition, propor-
tion of cells in G0/G1 fell from 36.8 to 19.1% compared
to control groups while percentages of S phase cells
almost retained the same levels. Results indicated that
S. striata extract induced G2/M cell cycle arrest in these
Jurkat cells in a dose-dependent manner.
Effect of S. striata extract on Jurkat cell DNA
fragmentation
To confirm effects of the extract on induction of apopto-
sis in the cell line, DNA products were examined for
appearance of characteristic DNA laddering in treated
cells. Ladder formation was detected after exposing the
cells with 100–200 lg/mL of extract. As shown in
Fig. 4, increased inter-nucleosomal DNA fragmentation
was dose dependently apparent in the cells, indicating
that the extract caused the cells to undergo apoptosis.
Discussion
In this study, we evaluated cytotoxic activity of S. stri-
ata extract on Jurkat human leukaemia cells. We found
that S. striata extract inhibited Jurkat cell population
growth in a dose- and time-dependent manner. More-
over, results indicated that extract up to 400 lg/ml had
no significant toxicity to normal PBMCs. It has been
shown previously that some anti-cancer effects of
medicinal plants are based on induction of apoptosis
(6,7,17–19). Apoptosis is a normal physiological process
that plays an important role in homeostasis and expan-
Figure 1. Effect of Scrophularia striata extract on viability of Jur-
kat human leukaemia tumour cells. Tumour cells were incubated
with selected concentrations (0–400 lg/ml) of extract for 48 h. Results
indicated that the extract significantly (*P < 0.05, **P < 0.001) inhib-
ited Jurkat cell population growth in a dose- and time-dependent man-
ner compared to non-treated (control group) cells. Results shown are
representative of three independent experiments.
Figure 2. Effect of Scrophularia striata extract on induction of apoptosis in Jurkat cells. Apoptosis-inducing effect of S. striata extract on Jur-
kat human leukaemia cells evaluated by the annexin V-FITC (AV)/PI method. Dot-plot graphs show viable cells (AV/PI), early phase apoptotic
cells (AV+/PI), late phase apoptotic cells (AV+/PI+) and necrotic cells (AV/PI+).
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sion of normal and cancer cells (20,21); also dysregula-
tion of apoptosis is usually considered to be a major
cancer cell property (22). Also, many studies have
shown that apoptosis is an important mechanism by
which various anti-cancer agents exert antitumour effects
(23,24). In previous studies, cytotoxic activity of some
species of Scrophularia have been reported on cancer
cell lines (12,25). Here, to determine whether cytotoxic-
ity of S. striata extract on Jurkat cells was related to
apoptotic cell death, percentages of apoptotic cells were
measured by annexin V-FITC/PI staining. Our results
indicated that proportions of apoptotic cells increased
with increasing concentration of S. striata extract. These
data indicated that cytotoxic effects of S. striata extract
seemed to be mediated by induction of apoptosis in the
Jurkat cells. In addition, one previous study has shown
that a further genus of Scrophularia, S. floribunda
extract, induced apoptosis in tumour cells through induc-
tion of cell cycle arrest (25). Thus, in this study, to
determine whether induction of apoptosis and anti-
tumour effects of S. striata extract on Jurkat cells was
associated with induction of cell cycle arrest, distribution
of cells in different phases of the cell cycle was evalu-
ated by measuring intracellular DNA content. Our find-
ing indicate that S. striata extract induced G2/M phase
cell cycle arrest in Jurkat cells in a dose-dependent man-
ner. On the other hand, the antioxidant, anti-inflamma-
tory and immunomodulatory activities of some species
of Scrophularia have also been shown by several inves-
tigators (10,12,26); S. striata has been used to treat vari-
ous inflammatory disorders (8,26,27). Our previous
studies indicated the inhibitory effect of S. striata
extract on pro-inflammatory mediator production by
macrophages including nitric oxide, TNF-a, IL-1b and
PGE2 production and also suppressive effects on matrix
metalloproteinases in the Wehi-164 tumour cell line in
vitro (8,9,13). In addition, antioxidant properties of com-
pounds such as iridoide glycosides and phenylpropanoid
esters isolated from S. buergeriana have been reported
(28–31). However, in our previous and present studies,
phenolic compounds, phenyl propanoids and two flavo-
noids, quercetin and isorhamnetin 3-O-rutinoside, were
identified from extracts of this plant (14). Several studies
showed that quercetin is a dietary antioxidant and also it
has anti-inflammatory and anti-tumour effects (32–36).
Moreover, other studies have shown that isorhamnetin
3-O-rutinoside induces apoptosis in human chronic mye-
logenous erythroleukaemia cells (K562) (37,38). This
plant extract in the present and previous studies is indi-
cated as having antioxidant, anti-inflammatory and anti-
tumour properties. Whether these compounds are the
main responsible agents for anti-tumour effects of
S. striata and are involved in this activity needs further
investigation. In conclusion, our findings here show that
S. striata has cytotoxic activity on Jurkat human leukae-
mia tumour cells. The ability of this plant to induce
apoptosis through G2/M phase cell cycle arrest on the
leukaemic cell line makes it a candidate for further stud-
ies to discover the active components involved and
mechanisms by which they induce apoptosis.
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